Selected article for: "acute infectious disease and severe pneumonia"
Author: Monteonofrio, Laura; Florio, Maria Cristina; AlGhatrif, Majd; Lakatta, Edward G; Capogrossi, Maurizio C
Title: Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease
  • Cord-id: b741whfj
  • Document date: 2020_12_11
    • ID: b741whfj
    Snippet: Coronavirus disease 2019 (COVID-19) is a new infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is frequently characterized by a marked inflammatory response with severe pneumonia and respiratory failure associated with multiorgan involvement. Some risk factors predispose patients to develop a more severe infection and to an increased mortality; among them, advanced age and male gender have been identified as major and independent risk factors for
    Document: Coronavirus disease 2019 (COVID-19) is a new infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is frequently characterized by a marked inflammatory response with severe pneumonia and respiratory failure associated with multiorgan involvement. Some risk factors predispose patients to develop a more severe infection and to an increased mortality; among them, advanced age and male gender have been identified as major and independent risk factors for COVID-19 poor outcome. The renin-angiotensin-aldosterone system (RAAS) is strictly involved in COVID-19 because angiotensin converting enzyme 2 (ACE2) is the host receptor for SARS-CoV-2 and also converts pro-inflammatory angiotensin (Ang) II into anti-inflammatory Ang(1–7). In this review, we have addressed the effect of aging and gender on RAAS with emphasis on ACE2, pro-inflammatory Ang II/Ang II receptor 1 axis and anti-inflammatory Ang(1–7)/Mas receptor axis.

    Search related documents:
    Co phrase search for related documents
    • ace activity decrease and activity expression: 1
    • ace enzyme and acei enzyme inhibitor: 1
    • ace enzyme and activator protein: 1
    • ace enzyme and activity expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • ace expression and acei enzyme inhibitor: 1
    • ace expression and activity expression: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • ace expression decrease and activity expression: 1
    • ace expression increase and activity expression: 1, 2
    • ace inhibitor and acei enzyme inhibitor: 1, 2
    • ace inhibitor and activity expression: 1, 2, 3, 4
    • ace promoter activity and activity expression: 1